Return-path: <mansoor.ahmed@bfbio.com>
Envelope-to: sales_marketing@ferozsons-labs.com
Delivery-date: Tue, 06 May 2014 11:44:17 -0700
Received: from localhost ([127.0.0.1]:40502 helo=secure143.inmotionhosting.com)
	by ld143.inmotionhosting.com with esmtpa (Exim 4.82)
	(envelope-from <mansoor.ahmed@bfbio.com>)
	id 1WhkLF-0004Nx-0p; Tue, 06 May 2014 11:43:49 -0700
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8;
 format=flowed
Content-Transfer-Encoding: 8bit
Date: Tue, 06 May 2014 11:43:48 -0700
From: mansoor.ahmed@bfbio.com
To: "Dr. Sohail Manzoor" <sohail.manzoor@ferozsons-labs.com>
Cc: sales_marketing@ferozsons-labs.com
Subject: Re: Breaking news Hep c breakthrough ORAL Product SOVALDI of GILEAD
 Sciences in Pakistan marketed by Ferozsons labs.
In-Reply-To: <CF8D9F59.3F281%sohail.manzoor@ferozsons-labs.com>
References: <CF8D9F59.3F281%sohail.manzoor@ferozsons-labs.com>
Message-ID: <f2fc2cd4e887e0f70298e3782b061075@bfbio.com>
X-Sender: mansoor.ahmed@bfbio.com
User-Agent: Roundcube Webmail/0.9.5

On 2014-05-05 16:01, Dr. Sohail Manzoor wrote:
> Dear Colleagues
> 
>  FEROZSONS LABS has made a marketing agreement with GILEAD SCIENCES
> to launch their BREAKTHROUGH product for hepatitis C in Pakistan
> 
> Gilead Sciences was founded in 1987 California , USA. Over the past 27
> years, they have grown to become one of the world's largest
> biopharmaceutical companies, with approximately 6,000 employees across
> five continents. -
> 
> The U.S. Food and Drug Administration approved SOVALDI (SOFOSBUVIR) to
> treat chronic hepatitis C virus (HCV) infection on December 6, 2013.
> 
> Sovaldi is the first drug that has demonstrated safety and efficacy to
> treat certain types of HCV infection without the need for
> co-administration of interferon. a significant shift in the treatment
> paradigm for _some patients with chronic hepatitis C._
> 
> Sovaldi is a nucleotide analog inhibitor that blocks a specific
> protein needed by the hepatitis C virus to replicate.
> 
> High CURE Rates
> 
> The sales trend of SOVALDI in world can make it THE BEST-SELLING NEW
> DRUG OF ALL TIME.
> 
> We are starting its patient name basis imports from today . This will
> be promoted by hepatology managers until registered which is in
> process in Pakistan.
> 
> The cost of one sovaldi 400 mg tablet is 1000 US $ ( 100000 Rs) in USA
> but SAME medicine made at SAME manufacturing plant with Same brand
> name BY Gilead sciences will be available through Ferozsons labs
> Pakistan at cost of 18 US $ ( 1785 Rs ). We have made a special system
> for its distribution too.
> 
> All such partnerships are giving YOU MORE OPPORTUNITIES TO GROW MORE
> BUSINESS WITH SCIENCE.
> 
> BEST WISHES FOR MAKING  SOVALDI A BLOCKBUSTER PRODUCT OF PAKISTAN
> WITH TEAM WORK.
> 
> Dr. Sohail Manzoor
> 
> Commercial Director
> Ferozsons Laboratories Limited.
> 5-KM, Sundar Raiwind Road, Raiwnd,
> Lahore.
> 
> Cell: +92 302 8229195
> Tel: +92 423 6026702
> Email: sohail.manzoor@ferozsons-labs.com


Dear sir "THIS IS THE CHANGE" this is very good drug and doctor is
waiting for this drug many time, and this drug doctor need. we achieve
our Aim very soon after this drug launch.

Best Regard
Mansoor Ahmed
Hepatology Associate
hyderabad
0335-4994452

